- Home
- BSVN vs LAB Comparison
BSVN vs LAB Comparison
Compare BSVN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSVN
- LAB
- Stock Information
- Founded
- BSVN 2004
- LAB 1999
- Country
- BSVN United States
- LAB United States
- Employees
- BSVN N/A
- LAB N/A
- Industry
- BSVN Major Banks
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- BSVN Finance
- LAB Industrials
- Exchange
- BSVN Nasdaq
- LAB Nasdaq
- Market Cap
- BSVN 410.8M
- LAB 462.4M
- IPO Year
- BSVN 2018
- LAB 2011
- Fundamental
- Price
- BSVN $48.31
- LAB $1.45
- Analyst Decision
- BSVN Buy
- LAB Buy
- Analyst Count
- BSVN 2
- LAB 2
- Target Price
- BSVN $53.50
- LAB $2.50
- AVG Volume (30 Days)
- BSVN 40.8K
- LAB 1.8M
- Earning Date
- BSVN 07-17-2025
- LAB 08-11-2025
- Dividend Yield
- BSVN 1.97%
- LAB N/A
- EPS Growth
- BSVN 36.22
- LAB N/A
- EPS
- BSVN 4.64
- LAB N/A
- Revenue
- BSVN $96,067,000.00
- LAB $169,687,000.00
- Revenue This Year
- BSVN N/A
- LAB N/A
- Revenue Next Year
- BSVN $3.53
- LAB $12.18
- P/E Ratio
- BSVN $10.52
- LAB N/A
- Revenue Growth
- BSVN 22.26
- LAB 33.86
- 52 Week Low
- BSVN $32.49
- LAB $0.92
- 52 Week High
- BSVN $50.26
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- BSVN 74.30
- LAB 66.47
- Support Level
- BSVN $44.60
- LAB $1.20
- Resistance Level
- BSVN $49.39
- LAB $1.41
- Average True Range (ATR)
- BSVN 1.24
- LAB 0.07
- MACD
- BSVN 0.28
- LAB 0.00
- Stochastic Oscillator
- BSVN 83.18
- LAB 83.33
About BSVN Bank7 Corp. Common stock
Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a variety of commercial and retail financial services. It offers deposit banking products, including commercial deposit services, commercial checking, money market, and other deposit accounts, and retail deposit services such as certificates of deposit, money market accounts, checking accounts, negotiable order of withdrawal accounts, savings accounts, and automated teller machine access. etc. It generates revenues from interest income from financial instruments and non-interest income and service charges on deposit accounts.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.